Abbreviations {#nomen0010}
=============

ABHD5

:   Alpha-beta hydrolase domain-containing 5

Ai

:   Atglistatin

ATGL

:   Adipose triglyceride lipase

BA

:   Brown adipocyte

BAY

:   BAY 59-9435

BSA

:   Bovine serum albumin

DAG

:   Diacylglycerol

Dox

:   Doxycycline

FA

:   Fatty acid

Gluc

:   *Gaussia* luciferase

HSL

:   hormone sensitive lipase

HTS

:   High-throughput screening

LBD

:   ligand binding domain

LD

:   lipid droplet

PDK4

:   Pyruvate dehydrogenase kinase 4

PKA

:   Protein kinase A

PGC1α

:   peroxisome proliferator-activated receptor gamma coactivator 1-alpha

PLIN1

:   Perilipin-1

PNPLA2

:   Patatin Like Phospholipase Domain Containing 2

PPARs

:   Peroxisome proliferator-activated receptors

RLUs

:   Relative Luminescence Units

ROI

:   Region of interest

SRC-1

:   Steroid receptor coactivator-1

TAG

:   Triacylglycerol

UCP1

:   Uncoupling protein 1

1. Introduction {#sec1}
===============

Fatty acids (FAs) are a significant energy source and substrates for membrane synthesis that are required for cellular growth and division. Importantly, recent work has identified a role for FAs as signaling molecules in regulating lipid homeostasis [@bib1]. On the other hand, excessive levels of FAs can lead to a build up of toxic lipid metabolic intermediates in a process termed lipotoxicity [@bib2]. This buildup of lipids can have negative effects that are causative in various metabolic disorders, such as diabetes [@bib3] and cardiovascular disease [@bib4]. However, our understanding of FA metabolism has been hampered by the lack of methods to detect their production in a temporal and spatial manner in live cells.

FAs are stored safely in the form of triacylglycerol (TAG) within lipid droplet (LD) organelles [@bib5]. During times of energy demand these stores are mobilized by lipases on the surface of LDs. In adipocytes, this process is mediated by the major lipases adipose triglyceride lipase (ATGL; also known as Patatin Like Phospholipase Domain Containing 2, PNPLA2), the rate limiting enzyme for TAG hydrolysis and hormone sensitive lipase (HSL), a major diacylglycerol (DAG) lipase [@bib6]. In brown adipocytes (BAs), FAs are essential regulators of thermogenesis [@bib7], [@bib8] by supplying energy for mitochondrial electron transport and functioning as allosteric activators of uncoupling protein 1 (UCP1) [@bib9], the molecular mechanisms for brown adipose tissue non-shivering thermogenesis.

Recent work has demonstrated that ATGL and HSL can regulate the transcription of various genes involved in FA metabolism and uncoupling such as peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α), pyruvate dehydrogenase kinase 4 (PDK4), and UCP1, likely by providing ligands for nuclear transcription factors peroxisome proliferator-activated receptors (PPARs) [@bib10], [@bib11], [@bib12], [@bib13]. However, the temporal and spatial regulation of how FAs might traffic to promote gene expression is not known. In addition, methods to detect real time mobilization of intracellular FAs are lacking. Here we describe the development of genetically-encoded sensors based upon the ligand-dependent interaction between PPARα and steroid receptor coactivator-1 (SRC-1) to image the production and trafficking of FAs by fluorescent and luminescent means.

2. Methods and experimental procedures {#sec2}
======================================

2.1. cDNA cloning and generation of cell lines {#sec2.1}
----------------------------------------------

Cloning for the PPARα ligand binding domain (LBD) and the SRC-1 fragment were previously described [@bib10]. Briefly, the bipartite FA sensor was generated by first cloning the LXXLL domain of SRC-1 (amino acids, aa; 620--770) on the C-terminus of EYFP (Clontech). The LBD of human PPARα (aa 191--467) was cloned on the C-terminus of full-length Perilipin-1 (PLIN1). The PLIN1- PPARα LBD fusion was then sub-cloned on the C-terminus of EYFP-SRC1 separated by a P2A sequence.

The cDNA for a monomeric luciferase FA sensor was commercially synthesized (Genewiz Inc.). Briefly, *Gaussia* luciferase (Gluc) was split into optimized N-terminal (aa 18--105; GlucN) and C-terminal fragments (aa 106--185; GlucC) as previous described [@bib14]. The GlucN fragment was followed by the LBD of PPARα, the LXXLL motif of SRC-1 and finally the GlucC fragment. Each fragment was separated by flexible linkers 2X(Gly-Gly-Gly-Gly-Ser). The synthesized DNA fragment containing AgeI and XbaI sites was cloned into the same sites of ECFP-C1.

The indicated constructs were cloned into the lentivirus vector (pINDUCER20) as previously described [@bib15], [@bib16]. For lentiviral packaging, pINDUCER20 target plasmid was co-transfected with pMD2.G and psPAX2 packaging vectors into HEK293T cells using lipofectamine LTX and plus reagent (Invitrogen). 48 h and 72 h post transfection, virus-containing culture media was harvested and passed through 0.45 μM filters to remove debris. To collect the virus, the media was centrifuged at 48,000× *g* for 2 h 4 °C in a Beckman 25.50 fixed angle rotor, and the virus pellet was resuspended in OPTIMEM. Stable brown adipocyte (BA) cells line expressing sensors were generated by infecting with virus for 24 h followed by G418 selection (800 μg/ml) for one week.

2.2. Cell culture {#sec2.2}
-----------------

HEK293T and COS-7 cells were purchased from ATCC. Mouse brown preadipocyte cells lines were generated in the labs of Dr. Bruce Spiegelman (Harvard University) or Dr. Gregory Steinberg (McMaster University) and were provided as gifts. All cells were maintained in DMEM High Glucose (Hyclone GE Lifesciences) with 10% FCS (Atlanta Biologicals) and Penicillin/Streptomycin (Hyclone, GE Lifesciences). Brown preadipocytes were differentiated by treating cells with induction medium (20 nM insulin, 1 nM T3, 0.5 mM isobutylmethylxanthine, 0.5 μM dexamethasone, and 0.125 mM indomethacin) for 48 h, followed by maintenance in differentiation media (20 nM insulin, 1 nM T3) until complete differentiation at 7 days. The expression of stably integrated sensors was induced by treating cells with 1 μg/ml doxycycline for 24--48 h.

2.3. Microscopy {#sec2.3}
---------------

Images were acquired using an Olympus IX-81 microscope equipped with a spinning-disc confocal unit. Microscope control and data acquisition were performed using CellSens Dimensions (Olympus) software. BAs grown and differentiated on 35 mm glass coverslips were imaged in HEPES-Krebs-Ringer buffer (Sigma) supplemented with 1% BSA (Alkali Scientific). EYFP fluorescent images were acquired using a 40 × (0.9 NA) or 60 × (1.2 NA) water immersion lens. EYFP reporter images were acquired every minute, with basal fluorescence recorded for the first 3--5 min, followed by stimulation of lipolysis (forskolin/IBMX, 2 μM and 200 μM; ABHD5 ligand; isoproterenol). The region of interest (ROI; lipid droplets, nucleus or cytoplasm) for each frame was quantified using ImageJ software (NIH) and the LD or nucleus ROI was normalized to cytoplasm to correct for any nonspecific changes in fluorescent intensity due to minor changes in excitation or focal plane. Data were then expressed as a fold of basal fluorescence.

2.4. Immunofluorescence {#sec2.4}
-----------------------

BAs grown on 35 mm glass coverslips were induced to express the fluorescent FA sensor for 48 h. Cells were treated with vehicle or Isoproterenol for 20 min as above for microscopy experiments. Fixed cells were permeabilized with phosphate-buffered saline containing 5% normal donkey serum and 0.01% saponin (Permeabilization buffer) for 15 min, then incubated for 50 min in Permeabilization buffer with primary antibody against PLIN1 (goat, 1:200, Everest Biotech, Cat\# EB07728). The slides were washed four times, 5 min each, with phosphate-buffered saline, then incubated for 1 h with Alexa Fluor 555 conjugated donkey anti-goat (1:1000; Invitrogen) in Permeabilization buffer. The slides were washed again, then counterstained for nuclei (4′,6-diamidino-2-phenylindole; 1:5000) in phosphate-buffered saline. Slides were finally washed with phosphate-buffered saline and imaged as above on an Olympus IX-81.

2.5. Gene expression analysis {#sec2.5}
-----------------------------

RNA was isolated from BAs using a Nucleospin RNA II kit (Machery-Nagel) as indicated by the manufacturer. Total RNA was reverse transcribed using Superscript III (Invitrogen) with oligo(dT) primers (ThermoFisher). Fifty nanograms of cDNA was analyzed in a 20-μl quantitative PCR reaction (ABsolute Blue QPCR SYBR; ThermoScientific) with 80 nM of primers. Expression data were normalized to the housekeeping gene peptidylprolyl *cis--trans* isomerase A (PPIA) using the ΔΔC~T~ method (2^−ΔΔCT^) [@bib17]. cDNAs were amplified using primers as previously described [@bib10].

2.6. Luciferase assays {#sec2.6}
----------------------

Immediately following treatments, cells were washed once with PBS and luciferase assays were performed by lysing cells in Gluc assay buffer (30 mM Tris pH 8.0, 300 mM NaCl, 0.1% Tween 20) [@bib18] for 20 min at room temperature with gentle rotation. Luciferase activity was measured by injecting coelenterazine (20 μM) in PBS and measuring luminescence over a 2 s integration.

2.7. Biochemical measurements {#sec2.7}
-----------------------------

Fatty acids released in the media were determined using a WAKO NEFA HR kit (Wako Pure Chemicals Industries) adapted to fluorescence detection with Amplex Red (Cayman Chemical). Glycerol was quantified using the Free Glycerol (Sigma) reagent with colorimetric determination.

3. Results {#sec3}
==========

3.1. Fluorescent imaging reveals dynamic trafficking of fatty acids from lipid droplets to nucleus {#sec3.1}
--------------------------------------------------------------------------------------------------

We previously described a fluorescent method to monitor the production of PPARα and PPARδ ligands on LDs [@bib10]. This assay involves targeting the ligand binding domain (LBD) of PPARα to the LD surface by fusing it to Perilipin 1 (PLIN1) and tagging the LxxLL motif of SRC-1 with EYFP. The presence of a FA (*i*.*e*., PPAR ligand) promotes the ligand dependent interaction between PPARα and SRC-1, which can be monitored by the accumulation of fluorescence at the LD surface. In addition to monitoring ligand production to genetically-targeted PPARα LBD, translocation of tagged SRC1 to endogenous nuclear receptors could provide a means of monitoring FA-induced transactivation in real time. To improve on the original design [@bib10], we incorporated the targeted LBD and fluorescent co-activator reporter into a single transcript using the P2A peptide to control relative expression levels. Furthermore, we put the construct under the control of a doxycycline inducible promoter ([Figure 1](#fig1){ref-type="fig"}A) and created a stable BA cell line that allowed controlled expression to detect the ligand dependent interaction ([Figure 1](#fig1){ref-type="fig"}B). In BA cells treated with doxycycline, EYFP-SRC-1 fluorescence was localized throughout the cytosol with some nuclear localization. Upon activation of protein kinase A (PKA) with forskolin/IBMX to stimulate lipolysis, fluorescent EYFP-SRC1 rapidly translocated to the LD surface (arrowheads; [Figure 1](#fig1){ref-type="fig"}C,D, Supplementary Movie 1), indicating that PPARα ligands (i.e. fatty acids) are immediately produced from LDs upon stimulation of lipolysis. Quantification of regions of interest (ROI) demonstrated a robust increase in EYFP fluorescence on the LD that occurred within 1--3 min of stimulating lipolysis. This early burst in the accumulation of EYFP was followed by a steady continuous accumulation in signal ([Figure 1](#fig1){ref-type="fig"}E). Somewhat unexpectedly, we also observed accumulation of EYFP-SRC1 within the nucleus (black arrows). The accumulation of EYFP-SRC1 in the nucleus steadily increased over 15 min and lacked the rapid phase observed at the LD surface ([Figure 1](#fig1){ref-type="fig"}F). We confirmed using immunofluorescence that the PLIN1-PPARα fusion remains on LD during stimulation ([Supplementary Figure 1](#appsec1){ref-type="sec"}). Thus, the translocation of EYFP-SRC1 to the nucleus most likely represents the FA-dependent interaction of EYFP-SRC1 with endogenous nuclear receptors ([Supplementary Figure 1](#appsec1){ref-type="sec"}). These data demonstrate the rapid mobilization of FAs on LDs and their detection in the nucleus.Figure 1**Design of a fluorescent sensor to detect fatty acid trafficking on lipid droplets and in the nucleus.** (**A**) Schematic for the design of a doxycycline (Dox) inducible bipartite fluorescent sensor to detect fatty acids. The co-activation domain of SRC1 is tagged to EYFP (EYFP-SRC1), separated by a P2A self-cleaving site with PLIN1-PPARα fusion, which targets the ligand binding domain of PPARα to lipid droplets. Dox binds reverse tetracycline-controlled transactivator (rtTA3), which promotes binding to the TRE2 promoter to induce expression of the fatty acid sensor. (**B**) In the presence of ligand (fatty acid; FFA), EYFP-SRC1 binds to PLIN1-PPARα on the surface of LDs. EYFP-SRC1 can also translocate to endogenous nuclear receptors that are sensitive to fatty acids. Stable expression of the fluorescent fatty acid reporter in brown adipocytes under basal conditions (**C**) and protein kinase A (PKA) stimulation (Stim; forskolin/IBMX) for 20 min (**D**). Arrows note accumulation of EYFP-SRC1 on lipid droplets while arrowheads note accumulation within the nucleus following stimulation. Quantification of the region of interest on lipid droplet (**E**) and nucleus (**F**) normalized to the cytosol signal and expressed as fold of basal.Figure 1

Supplementary video related to this article can be found at [https://doi.org/10.1016/j.molmet.2019.08.012](10.1016/j.molmet.2019.08.012){#intref0010}
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ATGL and HSL are the major adipocyte lipases which differ in their targeted substrates and mode of activation [@bib6], [@bib19]. In the basal state ATGL has weak TAG lipase activity; however, PKA activation phosphorylates PLIN1 to release the co-activator alpha-beta hydrolase domain-containing 5 (ABHD5, also known as CGI-58) [@bib20], which then activates ATGL [@bib19]. In contrast, HSL is directly phosphorylated by PKA, which targets the lipase to LD surfaces and increases its activity [@bib21], [@bib22]. Both ATGL and HSL contribute to adipocyte lipolysis, acting as selective TAG and DAG lipases, respectively, yet how these lipases contribute the temporal and spatial mobilization of FAs has not been investigated. As shown in [Figure 2](#fig2){ref-type="fig"}A, activation of β-adrenergic receptors with isoproterenol (Iso) triggered a burst of EYFP-SRC1 fluorescence on LD surfaces within 2 min of activation, followed by a steady increase over the next 15 min. Pharmacological inhibition of HSL with BAY 59--9435 (BAY) [@bib23] eliminated the rapid rise in fluorescence associated with LDs, but left largely intact the slower rise observed in control cells. Conversely, the rapid phase of FA mobilization was intact in the presence of ATGL inhibition with Atglistatin (Ai) [@bib24], yet enduring mobilization of FAs was largely eliminated in the absence of ATGL activity ([Figure 2](#fig2){ref-type="fig"}A). These observations indicate that HSL can mediate a very rapid mobilization of FAs, and that ATGL is critical for sustained mobilization. Furthermore, results indicate that both lipases function in concert to achieve a full lipolytic response, consistent with experiments that monitor extracellular accumulation of FAs ([Supplementary Figure 2](#appsec1){ref-type="sec"}).Figure 2**Role of ATGL, HSL and ABHD5 in fatty acid trafficking from lipid droplets and in the nucleus.** Individual contribution of ATGL and HSL to fatty acid signaling on lipid droplets (**A**) and in the nucleus (**B**). Combined contribution of both ATGL and HSL to fatty acid signaling on lipid droplets (**C**) and in the nucleus (**D**). Cell were pretreated with DMSO (in the case for Iso alone) or in the presence of ATGL inhibitor (Ai, 10 μM), HSL inhibitor (BAY, 5 μM), or both inhibitors for 20 min, then imaged basally for three minutes, followed by stimulation with isoproterenol (Iso, 1 μM) for 15 min. Role of direct ABHD5 activation on fatty acid signaling on lipid droplets (**E**) and in the nucleus (**F**). Brown adipocytes were imaged basally for 3 min followed by stimulation with Isoproterenol (Iso, 1 μM) or ABHD5 activation (SR-3420, 20 μM) for 15 min. The region of interest on lipid droplet, nucleus was quantified and normalized to the cytosol signal and expressed as fold of basal.Figure 2

Fluorescent-tagged SRC-1 accumulation in the nucleus showed somewhat different kinetics, with no detectible burst and a slow accumulation that was similarly sensitive to inhibition of ATGL or HSL ([Figure 2](#fig2){ref-type="fig"}B). Consistent with the notion that ATGL and HSL are the major adipocyte lipases, dual inhibition of ATGL and HSL completely blocked the accumulation of EYFP-SRC1 ([Figure 2](#fig2){ref-type="fig"}C) on LDs and reduced accumulation in the nucleus by greater than 80% ([Figure 2](#fig2){ref-type="fig"}D). These data demonstrate that FAs can traffic from the LD to the nucleus through the function of ATGL and HSL and that these enzymes differ in their kinetics of FA mobilization on LDs.

The results with lipase inhibition indicate that PKA-induced HSL activation mediates rapid FA mobilization, whereas the sustained phase of LD-mediated FA signaling requires ATGL that might be independent of transmembrane signaling. To address the role of PKA activation in the temporal control of lipolysis, we compared receptor mediated-activation by Iso with that induced by ABHD5 ligands, which activate ATGL-dependent lipolysis directly [@bib15], [@bib25]. These ligands stimulate lipolysis by binding ABHD5, reducing its affinity for PLIN1, thereby stimulating ATGL-dependent lipolysis independently of PKA. As expected, Iso promoted the increase in EYFP-SRC1 with two distinct phases, while direct activation of ABHD5 with SR-3420 promoted the steady accumulation of EYFP-SRC1 on the LD surface that lacked the initial burst observed with receptor activation ([Figure 2](#fig2){ref-type="fig"}E). Interestingly, the profile of EYFP-SRC1 accumulation on LDs triggered by SR-3420 mimicked that of receptor mediated lipolysis when it was driven exclusively by ATGL ([Figure 2](#fig2){ref-type="fig"}A, BAY/Iso). The accumulation of EYFP-SRC1 within the nucleus was similar whether lipolysis was induced via activation of β-adrenergic receptors with isoproterenol or triggered by activation of ABHD5 with SR-3420 ([Figure 2](#fig2){ref-type="fig"}F). Overall, these results demonstrate that direct activation of lipolysis is sufficient to promote FA trafficking from LDs to the nucleus.

The accumulation of EYFP-SRC1 within the nucleus suggested that FAs might traffic to the nucleus to modulate gene transcription via endogenous nuclear receptors. Because the fragment of SRC-1 used as a reporter lacks the activation domain, we reasoned that binding of this reporter to endogenous transcription factors might function as a dominant-negative to suppress the transcription of genes responsive to FA production. As shown in [Figure 3](#fig3){ref-type="fig"}A, Iso increased the expression of known PPAR target genes that are involved in fatty acid oxidation (PGC1α, PPARα, PDK4) and UCP1. Furthermore, doxycycline-induced expression of EYFP-SRC1 (+Dox) lowered the expression of these genes but not expression of NOR-1 [@bib10], a direct PKA target gene. ([Figure 3](#fig3){ref-type="fig"}A). Importantly, the expression of the SRC-1 fragment did not affect the release of FAs ([Supplementary Figure 3](#appsec1){ref-type="sec"}). Overall, these results indicate a LD to nucleus pathway that communicates the metabolic status of the cell to rapidly regulate the expression of genes involved in fatty acid oxidation and uncoupling.Figure 3**The dominant-negative fragment of SRC-1 suppresses the induction of known PPAR target genes.** Brown adipocyte cells stably expressing the SRC-1 fragment in a doxycycline-inducible manner were treated with (+Dox) or without (-Dox) doxycycline (1 μg/ml) for 48 h, followed by vehicle (Ctl) or Isoproterenol (Iso, 10 μM) for four hours. The RNA was extracted, and the expression of the indicated genes was measured. \*p \< 0.05 and \*\*\*p \< 0.001 indicate a significant effect of doxycycline-induced expression of EYFP-SRC-1 on the expression of genes induced by isoproterenol treatment (Iso) as determine by two-way ANOVA with Bonferroni post t-test. n.s. indicates a non-significant effect.Figure 3

3.2. A high throughput luciferase-based sensor to detect intracellular fatty acids {#sec3.2}
----------------------------------------------------------------------------------

The fluorescent reporter provides local information on FA signaling. We next sought to determine whether the sensor system described could be adapted for high-throughput screening (HTS). To do so, we engineered luciferase complementation based on optimized fragments for a split *Gaussia* luciferase (Gluc) [@bib26] into a single genetically-encoded reporter ([Figure 4](#fig4){ref-type="fig"}A). In HEK 293T cells transiently transfected with the luciferase sensor, the addition of PPAR ligands resulted in an increase in luciferase signal in response to PPARα ligands Wy14-643 (Wy) and GW7647, but not PPARγ ligand rosiglitazone ([Figure 4](#fig4){ref-type="fig"}B). A dose response for Wy resulted in a calculated EC~50~ of 0.54 μM, similar to the reported EC~50~ values for this ligand ([Figure 4](#fig4){ref-type="fig"}C) [@bib27], [@bib28]. Overall, these results demonstrate that the luminescent based sensor is selectively responsive to PPARα ligands.Figure 4**Design of a monomeric luminescent sensor to detect fatty acids.** (**A**) Schematic for the design of monomeric luciferase sensor to detect fatty acids. The N-terminal fragment of gaussia luciferase (Gluc) was fused in tandem with the ligand binding domain of PPARα, the LxxLL motif of SRC-1 and the C-terminal domain of Gluc. Fragments were separated by glycine/serine flexible regions. (**B**) Brown pre-adipocytes stably expressing the Gluc fatty acid sensor were treated with the indicated PPAR ligands (Wy 14--643, 100 μM (Wy); GW7647, 1 μM; Rosiglitazone, 1 μM (Rosi)) and the Relative Luminescence Units (RLUs) were determined and expressed as a fold of DMSO. Data are from three independent experiments performed in triplicate. \*\*\*p \< 0.001 indicates a significant effect compared to DMSO as determined by one-way ANOVA. (**C**) Dose response for the PPARα ligand Wy in 293T cells transfected with the Gluc fatty acid sensor. Data are from one experiment performed in quadruplicate and is representative of three independent experiments.Figure 4

We speculated that the PPARα Gluc sensor would be responsive to exogenous and endogenous FAs, which might provide a useful means of detecting intracellular lipolysis. To test the utility of the sensor we generated a stable BA cell line where the expression of the Gluc FA sensor could be controlled in doxycycline inducible manner. We first examined whether the luciferase sensor could detect exogenous FAs. Addition of oleic acid to cells increased the luciferase signal in a dose-responsive manner ([Figure 5](#fig5){ref-type="fig"}A). We next examined whether the luciferase sensor could detect endogenous FAs. BA cells were grown and differentiated, and the expression of the sensor was induced with doxycycline treatment for 24--48 h. Stimulation of lipolysis with the selective β3-adrenoreceptor agonist CL 316,243 (CL) increased lipolysis over a range of doses as determined by the accumulation of extracellular FAs, with a EC~50~ of 8.5 nM ([Figure 5](#fig5){ref-type="fig"}B), similar to that previously reported [@bib29]. The luciferase sensor similarly increased reporter activity in a dose responsive manner with a calculated EC~50~ of 3.9 nM, demonstrating the utility of the sensor to detect FAs over a range of lipolysis activation ([Figure 5](#fig5){ref-type="fig"}C). We then examined whether the sensor was sensitive to inhibition of lipolysis. Treatment of BA cells with an inhibitor of HSL (BAY), the rate limiting enzyme for the hydrolysis of DAG, resulted in a reduction in luciferase activity when lipolysis was stimulated, but not under basal conditions ([Figure 5](#fig5){ref-type="fig"}D). We reasoned that the luminescent sensor was reporting the level of intracellular FAs. To test this, we increased the concentration of intracellular FAs by systematically lowering extracellular bovine serum albumin (BSA), the functional acceptor for FA efflux [@bib30]. As expected, stimulation of the β-adrenergic receptor with Iso increased luminescence in cells incubated with 1% BSA and this effect was increased when the concentration of BSA was lowered to 0.1% and no BSA (0% BSA) ([Figure 5](#fig5){ref-type="fig"}E). When lipolysis was directly stimulated with ABHD5 ligand (SR-3420), which by-passes PKA signaling and negative feedback regulation on adenylyl-cyclase [@bib30], the effect was lower compared to Iso in the presence of 1% BSA. However, when the concentration of BSA was lowered to 0.5%, 0.1% and no BSA, SR-3420 had a much greater increase in luciferase activity. Lowering the concentration of BSA in the medium did not affect luciferase activity under basal conditions ([Figure 5](#fig5){ref-type="fig"}E). Overall, these data indicate that the luciferase sensor detects production of intracellular FA levels.Figure 5**The luminescent fatty acid sensor is sensitive to exogenous and endogenous fatty acids.** (**A**) Effect of exogenous fatty acids on the activity of the luminescent fatty acid sensor in undifferentiated pre-brown adipocytes. Cells were treated with different fatty acid concentrations and the Relative Luminescence Units (RLUs) were determined and expressed as a fold of bovine serum albumin (BSA). Dose response for CL-316,243 in differentiated BA as determined by measuring free fatty acids (FFA) in the media (**B**) or RLUs (**C**). (**D**) The Gluc fatty acid sensor is sensitive to inhibition of lipolysis. Differentiated BA were pretreated with the HSL inhibitor (BAY, 5 μM) followed by stimulation with forskolin/IBMX (Stim) and Relative Luminescence Units (RLUs) were determined. \*\*\*p \< 0.001 indicates a significant effect of HSL inhibition as determine by two-way ANOVA with Bonferroni post t-test. (**E**) The Gluc fatty acid sensor detects intracellular fatty acids. Differentiated BA were incubated in the indicated concentrations of bovine serum albumin (BSA) and treated with isoproterenol (Iso, 1 μM) or ABHD5 ligands (SR-3420, 20 μM). \*p \< 0.05, \*\*\*p \< 0.001 indicates a significant effect of BSA concentration compared to 1% BSA within the same treatment group. ^&&^p \< 0.01 indicates a significant difference between Isoproterenol (Iso) and SR-3420 as determined by two-way ANOVA with Bonferroni post t-test. Results are from one experiment performed in sextuplet and is representative of three independent experiments.Figure 5

We also examined whether cells expressing the luciferase reporter were amenable to culture in multi-well format for more high-throughput analysis. Brown pre-adipocyte cells were cultured directly in 96-well clear-bottom white luminescent plates. We first tested the sensitivity of the luciferase sensor to detect FAs of different chain length and saturation. Luminescence increased progressively with greater FA chain length starting with octanoic acid (C8:0), with long chain unsaturated FAs (C18:3, C18:1 and C22:6) demonstrating the greatest increase in luminescence ([Figure 6](#fig6){ref-type="fig"}A). Finally, we examined the utility of the FA luminescent sensor to screen for activators and inhibitors of lipolysis in a 96-well plate. The general β-AR agonist isoproterenol and chemical ABHD5 ligands SR-4995, SR-4559, and SR-3420 increased luminescent reporter activity ([Figure 6](#fig6){ref-type="fig"}B). The calculated Z\' score from this assay was 0.627, indicating that the assay is sufficiently reliable for HTS [@bib31]. The effects of isoproterenol and ABHD5 ligands were partly reduced with HSL inhibition, whereas inhibition of ATGL suppressed reporter activity to a greater degree. The efflux of FAs into the extracellular media paralleled the activity of the luciferase reporter ([Figure 6](#fig6){ref-type="fig"}C). The relationship between RLUs and FA concentration in this assay showed a linear response with a coefficient of determination of 0.95 ([Figure 6](#fig6){ref-type="fig"}D). These data indicate that the luminescent reporter detects lipolysis induced by different modes of chemical activation (receptor or ABHD5) and is amenable to high-throughput analysis.Figure 6**The luminescent fatty acid sensor is amenable to high-throughput analysis.** (**A**) Effect of fatty acids of varying chain length and saturation on the luminescent fatty acid sensor in undifferentiated pre-brown adipocytes. Cells grown in 96-well plate were treated with 400 μM of the indicated fatty acids and the Relative Luminescence Units (RLUs) were determined. (**B** and **C**) The luminescent fatty acid sensor is sensitive to various activators and inhibitors of lipolysis. Brown adipocytes were grown and differentiated in white 96-well plates and were then treated with activators (Isoproterenol, 1 μM; SR-4995, SR-4559, SR-3420, 20 μM) and inhibitors of lipolysis for 30 min and the RLUs in cells (**B**) or mobilized free fatty acids (FFA) in media were determined (**C**). (**D**) Correlation between RLUs and FFA from **Figure 6 B** and **D**.Figure 6

4. Discussion {#sec4}
=============

Our ability to understand the role of FAs in metabolic homeostasis has been hampered by limitations to image and detect their production in cells. To address this barrier, we have developed genetically-encoded sensors that detect FAs by fluorescent and luminescent means. Using a fluorescent approach, we are able to image the temporal and spatial dynamics of FA trafficking within cells. Furthermore, a luminescent-based monomeric sensor reports intracellular FA levels and is amenable to high-throughput analysis. Using these approaches, we have improved our understanding of how FAs traffic and function within a cell.

Our previous work and that of others suggested a role for lipolytic enzymes in providing signaling molecules to regulate gene transcription [@bib10], [@bib12], [@bib13]; however, the temporal and spatial dynamics for this regulation have not been addressed. Using a fluorescence imaging approach, we took advantage of the ligand-dependent interaction between PPARα and SRC-1 and demonstrate that FAs produced by LDs can traffic to the nucleus within minutes of stimulating lipolysis. The exact mechanism by which FAs traffic from the LDs to the nucleus is currently unknown but might involve lipid binding proteins, such as fatty acid binding protein (FABP) 1 and 4, that traffic the ligands [@bib32], [@bib33]. ATGL and HSL are the major lipases in adipocytes; HSL is activated by phosphorylation and translocation to LDs, whereas ATGL is indirectly activated by the release of its co-activator ABHD5 from the scaffold protein PLIN1. Indeed, we found that the kinetics of ATGL and HSL signaling on LDs differed, with HSL activation required for the initial burst of FA release, and ATGL showing a steady increase in FA production on LDs. In contrast, both enzymes had a similar effect on promoting signaling in the nucleus, consistent with both enzyme regulating gene expression [@bib10], [@bib12], [@bib34]. We also examined the effects of direct ABHD5 activation, independent of PKA stimulation, on lipid signaling. Interestingly, the effect of direct activation of ABHD5 (SR-3420) on FA production on LDs ([Figure 2](#fig2){ref-type="fig"}E) was similar to that which was seen when lipolysis was driven only by ATGL (i.e. with HSL inhibition, [Figure 2](#fig2){ref-type="fig"}A). However, direct stimulation of ABHD5 resulted in an increase of FAs signaling to the nucleus similar to that of receptor activation (Iso), suggesting that direct stimulation of lipolysis is sufficient to promote signaling to the nucleus. Studies are currently underway to determine the effects of direct stimulation of ABHD5 on gene transcription.

The accumulation of EYFP-SRC1 in the nucleus was somewhat surprising since the exogenous PPARα ligand binding domain was targeted to the LDs, suggesting that SRC-1 was trafficking to the nucleus in a ligand-dependent manner to bind endogenous nuclear receptors. Indeed, the binding of the SRC-1 fragment, lacking an activation domain, suppressed lipolysis-induced transcription of known PPAR target genes. However, pharmacological inhibition of both ATGL and HSL did not completely block the accumulation of EYFP-SRC1 within the nucleus (approximately 80% inhibition), suggesting that PKA-dependent effects on nuclear import or FA trafficking might exist [@bib35], [@bib36].

Quantification of FAs typically involves biochemical assays that use colorimetric or fluorescence-based methods to detect extracellular levels. In addition, classical assays for determining PPAR transcriptional activity require transcription/translation events that can take several hours [@bib27]. We reasoned that we could further take advantage of the ligand-dependent interaction between PPARα and SRC-1 to develop a monomeric sensor based on split Gluc. This sensor is able to detect synthetic PPARα ligands and endogenous FAs. Screening of FAs of varying chain length and saturation demonstrates that long-chain unsaturated FAs are potent PPARα ligands [@bib27]. In BAs, the sensor accurately reports known potencies of a β3-AR agonist to stimulate lipolysis and PPARα agonists to induce gene transcription. Culture of BAs stably expressing the sensor in white 96-well format to test activators and inhibitors of lipolysis demonstrates that the sensor is amenable to HTS. Targeting lipolysis is of therapeutic interest, [@bib1], [@bib15] and the sensor could be used to screen for novel pharmacological probes that regulate lipolysis and/or PPARα ligands. Finally, expression of the luciferase sensor in transgenic animals could be used as an in vivo probe to monitor dynamics of FA production, uptake, and clearance, thereby improving our understanding of FA metabolism and their potential lipotoxic effects.

5. Conclusions {#sec5}
==============

In summary, we have developed genetically-encoded sensors to determine the temporal and spatial dynamics of FA production, that typically would not be possible using more conventional approaches. Given the increased interest in studying FA metabolism and ever-expanding obesity epidemic confronting our society, the use of these sensors will further improve our understanding of FA trafficking and metabolism.
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Appendix A. Supplementary data {#appsec2}
==============================

The following are the Supplementary data to this article:Figure S1**Supplementary Figure 1. Localization of PLIN1 exclusively to lipid droplets under basal and stimulation conditions.** Brown adipocytes induced to express EYFP-SRC1 and PLIN1-PPARα, were treated with vehicle control (Basal) or stimulated for 20 min (1 μM Iso), washed with PBS and fixed with 4% paraformaldehyde. Cells were then permeabilized, stained, and imaged for PLIN1 (pseudocolored red), nuclei (DAPI, pseudocolored blue) and EYFP-SRC1 (pseudocolored green). Merged images (PLIN1 + EYFP-SRC1) show that PLIN1 is localized exclusively to lipid droplets under basal and stimulated conditions and does not localize to the nucleus.Figure S1Figure S2**Supplementary Figure 2. Role of HSL and ATGL in the release of fatty acids and glycerol.** Quantification of free fatty acids (FFA; **a**) and glycerol (**b**) from brown adipocytes in [Figure 2](#fig2){ref-type="fig"}A pretreated with HSL inhibitor (BAY) or ATGL inhibitor (Atglitstatin; Ai), followed by stimulation of lipolysis with isoproterenol (Iso) for 15 min. \*p \< 0.05, \*\*p \< 0.01 and \*\*\*p \< 0.001 indicates a signification effect compared to Iso as determined by one-way ANOVA with Dunnett's multiple comparison post t-test.Figure S2Figure S3**Supplementary Figure 3. Expression of the SRC-1 fragment does not have an effect on lipolysis**. Brown adipocytes from [Figure 3](#fig3){ref-type="fig"} were treated as described and the release of free fatty acids (FFA) in the media was quantified.Figure S3
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